New injection tested for severe eczema relief
Disease control
Recruiting now
This study is testing whether an experimental drug called TRIV-509 helps adults with moderate to severe eczema. About 90 participants will receive either TRIV-509 or a placebo injection for 16 weeks, then switch to the other treatment. Researchers will measure skin improvement an…
Phase: PHASE2 • Sponsor: Triveni Bio • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC